The National Medicines Safety Agency has been informed of this death which “is the subject of a clinical investigation”. For the moment, “there is no evidence to support the role of the vaccine”.
A 26-year-old medical student was found dead Thursday, March 18, in Nantes, found West France Monday March 22. According to information from the regional daily, the young man, from La Turballe (Loire-Atlantique), was vaccinated at AstraZeneca on March 8. The Nantes prosecutor’s office opened an investigation into the causes of death and also ordered an autopsy.
Read also :AstraZeneca, the ambitious laboratory that has become Europe’s pet peeve
Anthony R., a sixth-year medical student, was found dead in his apartment locked from the inside by firefighters alerted by the young man’s family, who worried about his silence. “The investigation made it possible to establish that the deceased person had been vaccinated against Covid 19 (Astra Zeneca) on March 8, 2021. A forensic autopsy was carried out on March 19, 2021, the conclusions of which were communicated to the public prosecutor’s office on the 22nd. March”, said the public prosecutor of Nantes, Pierre Sennès, in a press release published Tuesday and quoted by AFP. “Additional analyzes” were also carried out. “As it stands, it is advisable to await the conclusions of these expertises to determine with certainty the causes of death”, he added.
SEE ALSO – “The benefits of the AstraZeneca vaccine outweigh its risks,” says WHO
«Investigation clinique»
As for the young man’s family, questioned by West France , she “Questions arise around the vaccine”. “It’s inevitable, his brother testified. Because my brother, beyond being someone brilliant, took care of him. He was careful what he ate, he played sports. Above all, he had no medical history, no illness, nothing. He was in perfect health. So this vaccine is the only branch we can hold on to to understand what happened».
The National Medicines Safety Agency (ANSM), responsible for monitoring vaccines against Covid-19, said that “The case is under clinical investigation”. “We have been informed of a case of death of a 24-year-old [24 ans selon l’ANSM et 26 ans selon le parquet NDLR] several days after vaccination with the AstraZeneca vaccine. At this stage, there is no evidence to support the role of the vaccine. This case of death is the subject of an in-depth clinical investigation by the regional pharmacovigilance centers (CRPV).“, also have specified the ANSM on its website.
During its last report, the ANSM has reported 4184 cases of adverse effects since the start of vaccination with AstraZeneca. The agency has, moreover, noted “13 cases of thromboembolic events (for more than 1,041,000 injections)”. In its report on March 18, after the suspension of the vaccine by fifteen European countries, the European Medicines Agency, concluded that the vaccine was not associated with an increased overall risk of blood clots. The use of AstraZeneca has therefore been able to resume in many European countries even if it is now authorized, in France, for people over 55 years old only.
– .
